China National Biotec Group - Strategic SWOT Analysis Review

Date: March 24, 2014
Pages: 24
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: CEE8BAE92F2EN
Leaflet:

Download PDF Leaflet

China National Biotec Group - Strategic SWOT Analysis Review
China National Biotec Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

China National Biotec Group (CNBG) is a biotechnology company. It undertakes the research, development, manufacture and marketing of various human health products such as vaccines, therapeutic products and diagnostic reagents. It manufactures more than 200 types of biological products for disease prevention, therapeutic and diagnostic use. Its product pipeline contains a live vector-based anti-HIV vaccine; a hepatitis B vaccine for therapeutic use; a shigella conjugate vaccine; and a trivalent rotavirus vaccine.

China National Biotec Group Key Recent Developments

Aug 29, 2013: CDIBP received an invention patent
Jun 20, 2013: MMR vaccine of SIBP has passed new GMP certification inspection

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

China National Biotec Group - Key Facts
China National Biotec Group - Key Employees
China National Biotec Group - Major Products and Services
China National Biotec Group - History
China National Biotec Group - Company Statement
China National Biotec Group - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

China National Biotec Group - Business Description
China National Biotec Group - Corporate Strategy
China National Biotec Group - SWOT Analysis
SWOT Analysis - Overview
China National Biotec Group - Strengths
Strength - Diversified Product Portfolio
Strength - Sturdy Research and Development Activities
Strength - Established Market
China National Biotec Group - Weaknesses
Weakness - Dependence on Third Parties
Weakness - Dependence on Single Geographical Region
China National Biotec Group - Opportunities
Opportunity - Strong Product Pipeline
Opportunity - Key Product Development and Approvasls
Opportunity - Biotech Focus
Opportunity - Market Potential: HCV
China National Biotec Group - Threats
Threat - Stringent Government Regulations
Threat - Competitive Pressures
Threat - Uncertain R&D Outcomes
Threat - Rapid Technological Changes
China National Biotec Group - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
China National Biotec Group, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

China National Biotec Group, Recent Developments
Aug 29, 2013: CDIBP received an invention patent
Jun 20, 2013: MMR vaccine of SIBP has passed new GMP certification inspection

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

China National Biotec Group, Key Facts
China National Biotec Group, Key Employees
China National Biotec Group, Major Products and Services
China National Biotec Group, History
China National Biotec Group, Other Locations
China National Biotec Group, Subsidiaries
China National Biotec Group, Key Competitors
China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
China National Biotec Group, Recent Deals Summary

LIST OF FIGURES

China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
China National Biotec Group, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

China National Biotec Group - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: